logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
TECX
Tectonic Therapeutic, Inc.
34.85
1 x 24.85
2 x 42.56
bid
ask
+
2.11
6.44%
10:02 AM
timesize
Ytd67.07%
1y65.24%
32.13
day range
34.85
14.39
52 week range
36.03
Open32.75Prev Close32.74Low32.13High34.85Mkt Cap657.59M
Vol35.01KAvg Vol197.29KEPS-4.46P/EN/AForward P/E-10.16
BetaN/AShort Ratio3.54Inst. Own46.91%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg29.29200-d Avg23.651yr Est74.67

TECX News

benzinga.com
Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform
benzinga.com
Tectonic Therapeutic Q1 EPS $(1.34) Misses $(1.18) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.34) per share which missed the a
benzinga.com
Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
Tectonic Therapeutic Q4 EPS $(1.03) Beats $(1.10) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.03) per share which beat the ana
benzinga.com
Here's How Much You Would Have Made Owning Tectonic Therapeutic Stock In The Last 5 Years

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Goodyear Tire Posts Downbeat Earnings, Joins BP, ON Semiconductor And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
Goodyear Tire Posts Downbeat Earnings, Joins BP, ON Semiconductor And Other Big Stocks Moving Lower

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarke

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

Truist Securities analyst Danielle Brill maintains Tectonic Therapeutic (NASDAQ:TECX) with a Buy

benzinga.com
Tectonic Therapeutic Q3 EPS $(1.02) Beats $(1.05) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.02) per share which beat the ana
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Targe

Oppenheimer analyst Leland Gershell initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
Truist Securities Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target

Truist Securities analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX)
benzinga.com
Raymond James Reinstates Outperform on Tectonic Therapeutic, Announces $76 Price Target

Raymond James analyst Michael Freeman reinstates Tectonic Therapeutic (NASDAQ:TECX) with a Outper
benzinga.com
Reported Saturday, Tectonic Therapeutic Presents Full Phase 1b Results For TX45 in PH-HFpEF Showing

Data confirmed TX45's tolerability profile and improvements in left ventricular function and pul
benzinga.com
Mizuho Maintains Outperform on Tectonic Therapeutic, Raises Price Target to $85

Mizuho analyst Uy Ear maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and raises t
benzinga.com
Tectonic Therapeutic Q1 EPS $(0.93) Beats $(1.22) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.93) per share which beat the ana

This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
benzinga.com
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mond
benzinga.com
Mizuho Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of

Mizuho analyst Uy Ear initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform

benzinga.com
Tectonic Therapeutic To Make Late-breaking Oral Presentation At ESC Heart Failure 2025 Congress High

WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("
benzinga.com
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $101

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight an
benzinga.com
Tectonic Therapeutic Q4 2024 GAAP EPS $(0.84) Beats $(1.39) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.84) per share which beat the ana
benzinga.com
Tectonic Therapeutic Raises $185M in PIPE Deal, Issuing Shares at Up to $54.14 Each

Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), today announced that it has entered i
benzinga.com
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Raises Price Target to $112

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight an
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Nasdaq Moves Lower; Meta Platforms Posts Strong Sales
benzinga.com
Nasdaq Moves Lower; Meta Platforms Posts Strong Sales

IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday
benzinga.com
IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big St

Dow Jumps Over 100 Points; Tesla Earnings Miss Views
benzinga.com
Dow Jumps Over 100 Points; Tesla Earnings Miss Views
benzinga.com
Market-Moving News for January 30th

IBM: 12% | IBM shares are trading higher after the company announced a collaboration agreement with

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
Tectonic Therapeutic Says Interim Results Show That TX45 Achieved Improvements In Hemodynamics Which

In the overall study population, TX45 achieved a 17.9% reduction in pulmonary capillary wedge pressu
benzinga.com
Tectonic Therapeutic To Host KOL Event On The Unmet Need In Group 2 PH-HFpEF And TX45 As A Potential

Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic") a clinical stage biotechnology company
benzinga.com
Raymond James Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Tar

Raymond James analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) wit
benzinga.com
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Raises Price Target to $79

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight an
benzinga.com
Leerink Partners Maintains Outperform on Tectonic Therapeutic, Raises Price Target to $69

Leerink Partners analyst David Risinger maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outpe
benzinga.com
Tectonic Therapeutic Announced Detailed Results From The Phase 1a Clinical Trial Of Its Lead Asset,

Phase 1a results support further development of TX000045 ("TX45") for Group 2 Pulmonary Hype
benzinga.com
Tectonic Therapeutic Q3 2024 GAAP EPS $(1.20) Misses $(0.84) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.20) per share which missed the a
benzinga.com
Tectonic Therapeutic To Present Phase 1a Data For Its Lead Asset TX000045 At AHA 2024

Tectonic Therapeutic, Inc. (NASDAQ:TECX) (Tectonic), a clinical stage biotechnology company focused

benzinga.com
Tectonic Therapeutic Announces Phase 1a Safety, Tolerability And PK/PD Results For Lead Program TX45

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relation